Skip to main content
Equibles
RMTI logo

RMTI · Rockwell Medical, Inc. · Metrics

Track RMTI — free

Use RMTI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RMTI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$8.04 +0.09 (+1.07%) At close · Sep 10
Rebalance outlook locked
Market Cap
$32.06M
Shares
4.03M

RMTI metrics

59 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$8.04
Market cap
$32.06M

Price action

20 metrics
Price change (1W)
-1.4%
Price change (30D)
+12.4%
Price change (3M)
—
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
—
Annualized volatility (3M)
—
Beta
—
RSI (14D)
59.2
Price vs SMA 50
—
Price vs SMA 200
—
Avg volume (3M)
32,375
Relative volume
0.7
Average dollar volume
$220,612

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
4.03M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.4×
reciprocal yield 227.2%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.5×
reciprocal yield 216.4%
P / book
0.9
reciprocal yield 109.4%
FCF yield
4.8%
TTM · current market cap
Buyback yield
—
P / FCF
20.8
reciprocal yield 4.8%
P / operating cash flow
11.1
reciprocal yield 9.0%
Earnings yield
-15.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
0.6×
reciprocal yield 156.7%
EV / revenue historical average (5Y)
0.5×
reciprocal yield 187.3%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
17.7%
Operating margin
-6.5%
Trailing 12 months
Net margin
-7.3%
Gross profit (TTM)
$12.29M
Operating profit (TTM)
−$4.52M
Net income (TTM)
−$5.08M
Trailing 12 months
Diluted EPS (TTM)
$-1.50
FCF margin
2.2%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$93.85

Growth

11 metrics
Revenue growth YoY
+10.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$69.39M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+15.4%
Year over year · more shares
Revenue CAGR (3Y)
-1.7%
Revenue CAGR (5Y)
+2.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-14.5%
Return on assets
-9.0%
Debt / equity
0.3
Current ratio
3.3
EBITDA (TTM)
−$2.43M
Free cash flow (TTM)
$1.54M
Quick ratio
3.0
Interest coverage
-4.0
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$1.52M
Latest balance sheet
Cash & equivalents
$10.52M
Total assets
$56.53M
Total debt
$9.00M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$2.90M
Capital expenditures (TTM)
$1.36M
R&D (TTM)
$40,000
SG&A (TTM)
$23.08M
Stock compensation (TTM)
$1.87M
R&D / revenue
—
Stock compensation / revenue
2.7%

Ownership (13F)

3 metrics
13F filers
36
13F filer change QoQ
-7
Institutional ownership
8.5%

Short interest

3 metrics
Short interest
2.3%
Latest settlement · 3.4 days to cover
Days to cover
3.4d
Short-squeeze score
69 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1041024 CUSIP 774374409 13F (30d) 21 filings 21 filers Visit website Investor relations